These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2804191)

  • 21. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clomipramine: an antiobsessive drug.
    Ananth J
    Can J Psychiatry; 1986 Apr; 31(3):253-8. PubMed ID: 3518904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of peripheral beta-blockade on psychophysiologic responses in obsessional neurotics.
    Rabavilas AD; Boulougouris JC; Perissaki C; Stefanis C
    Compr Psychiatry; 1979; 20(4):378-83. PubMed ID: 455955
    [No Abstract]   [Full Text] [Related]  

  • 24. Physiologic responses to loud tones in Israeli patients with posttraumatic stress disorder.
    Shalev AY; Orr SP; Peri T; Schreiber S; Pitman RK
    Arch Gen Psychiatry; 1992 Nov; 49(11):870-5. PubMed ID: 1444725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral electrodermal habituation-dishabituation and resting EEG in remitted schizophrenics.
    Iacono WG
    J Nerv Ment Dis; 1982 Feb; 170(2):91-101. PubMed ID: 7057175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.
    McTavish D; Benfield P
    Drugs; 1990 Jan; 39(1):136-53. PubMed ID: 2178909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrodermal activity in antidepressant medicated and unmedicated depressive patients and in matched healthy subjects.
    Thorell LH; Kjellman BF; d'Elia G
    Acta Psychiatr Scand; 1987 Dec; 76(6):684-92. PubMed ID: 3442260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
    Black DW; Kelly M; Myers C; Noyes R
    Biol Psychiatry; 1990 Feb; 27(3):319-27. PubMed ID: 2154266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [First observations on the association of imipramine and butyrrilperazine in the treatment of obsessive-phobic psychoneuroses].
    Ciani N; Silipo P
    Gazz Int Med Chir; 1964 Dec; 68(24):Suppl:3152-62. PubMed ID: 4378535
    [No Abstract]   [Full Text] [Related]  

  • 30. Obsessive-compulsive disorder and serotonin: is there a connection?
    Insel TR; Mueller EA; Alterman I; Linnoila M; Murphy DL
    Biol Psychiatry; 1985 Nov; 20(11):1174-88. PubMed ID: 2413912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological responses to brain stimulation during limbic surgery: further evidence of anterior cingulate modulation of autonomic arousal.
    Gentil AF; Eskandar EN; Marci CD; Evans KC; Dougherty DD
    Biol Psychiatry; 2009 Oct; 66(7):695-701. PubMed ID: 19545859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrodermal orienting activity in children with Down syndrome.
    Martìnez-Selva JM; Garcìa-Sánchez FA; Florit R
    Am J Ment Retard; 1995 Jul; 100(1):51-8. PubMed ID: 7546636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is hyperarousal essential to obsessive-compulsive disorder? Diminished physiologic flexibility, but not hyperarousal, characterizes patients with obsessive-compulsive disorder.
    Hoehn-Saric R; McLeod DR; Hipsley P
    Arch Gen Psychiatry; 1995 Aug; 52(8):688-93. PubMed ID: 7632122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imipramine and alprazolam effects on stress test reactivity in panic disorder.
    Roth WT; Margraf J; Ehlers A; Haddad JM; Maddock RJ; Agras WS; Taylor CB
    Biol Psychiatry; 1992 Jan; 31(1):35-51. PubMed ID: 1543796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart Rate Variability and Skin Conductance During Repetitive TMS Course in Children with Autism.
    Wang Y; Hensley MK; Tasman A; Sears L; Casanova MF; Sokhadze EM
    Appl Psychophysiol Biofeedback; 2016 Mar; 41(1):47-60. PubMed ID: 26341093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expectations and placebo responses to caffeine-associated stimuli.
    Flaten MA; Aasli O; Blumenthal TD
    Psychopharmacology (Berl); 2003 Sep; 169(2):198-204. PubMed ID: 12759808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
    Arch Gen Psychiatry; 1991 Aug; 48(8):730-8. PubMed ID: 1883256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
    Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M
    Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoxetine treatment of obsessive-compulsive disorder.
    Solyom L; Solyom C; Ledwidge B
    Can J Psychiatry; 1991 Dec; 36(10):723-7. PubMed ID: 1790516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.